About the correct way and safe dosage of ceftobiprom

Ceftobiprole medocaril is an injectable cephalosporin antibiotic that kills bacteria by preventing the formation of the bacterial cell wall. It does this by binding to essential penicillin-binding proteins (PBPs) and blocking the activity of enzymes necessary for the formation of the peptidoglycan layer of the bacterial cell wall. Ceftobiprole has high affinity for several PBPs commonly associated with bacterial resistance. To reduce the risk of drug resistance and maintain the effectiveness of the antibiotic, ceftobiprol should only be used to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Ceftobiprom is indicated for the treatment of Staphylococcus aureus bloodstream infections in adults(Bacteremia) (SAB), including right-sided infective endocarditis and acute bacterial skin and skin structure infections in adults(ABSSSI)and community-acquired bacterial pneumonia(CABP) in adults and children 3 months and older.

For adult patients, when treating bacteremia (SAB), intravenous injection of 667 mg (concentration < /span>2.67 mg/mL) for 2 hours, and then every 8 hours, for a maximum duration of 42 days. To treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) intravenously every 8 hours667mg (concentration of 2.67mg/mL) for 2 hours, for a total treatment time of 5-14 days.

For pediatric patients 12 years old to 18 years old, 13.3mg/kg should be administered intravenously every 8 hours during treatment (the maximum dose is 667mg and the concentration is 2.67mg/mL) lasts for 2 hours, and the treatment time is 7-14 days. For pediatric patients from 3 months to 12 years old, intravenous injection of 20mg/kg every 8 hours during treatment (maximum dose The amount is 667mg, the concentration is 5.33mg/mL) lasting 2 hours, and the same treatment time is 7-14 days.

When taking ceftobiprole, the dosage adjustment method mainly includes calculating the appropriate dose based on the patient's weight and infusing it strictly according to the treatment time. For different indications, the infusion time and frequency are different, and should be carried out in accordance with the doctor's instructions. The correct method and safe dosage of ceftobiprom are crucial to ensure efficacy and reduce adverse reactions.

Reference link:https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218275s000lbl.pdf